Relafen and Centrum drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Relafen (nabumetone) and Centrum (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include blood calcium increased among females and arthralgia among males.
The phase IV clinical study analyzes what interactions people have when they take Relafen and Centrum. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.
What is Relafen?
Relafen has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 6,243 Relafen users. Check the latest studies of Relafen.
What is Centrum?
Centrum has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 34,686 Centrum users. Check the latest studies of Centrum.
81 people who take Relafen and Centrum together, and have interactions are studied.

What are the common drug interactions of Relafen and Centrum, by gender? *:
female:
- Blood calcium increased
- Calcium ionised increased
- Dental caries
- Haemoglobin decreased
- Mouth ulceration (mouth ulcers)
- Stomatitis (inflammation of mucous membrane of mouth)
- Bone disorder
- Dental fistula
- Dermatitis allergic (inflammation of the skin due allergic reaction)
- Oropharyngeal pain
male:
- Arthralgia (joint pain)
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Asthenia (weakness)
- Atelectasis (partial or complete collapse of the lung)
- Bone pain
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Cerebral small vessel ischaemic disease (inadequate blood supply to small blood vessel of brain)
- Chest discomfort
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Contusion (a type of hematoma of tissue in which capillaries)
What are the common drug interactions of Relafen and Centrum, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Anxiety
- Asthenia (weakness)
- Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
- Back pain
- Blood calcium increased
- Bone disorder
- Bone loss
- Bone marrow oedema (inflammation that causes much than the needed fluid in a bone)
- Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
- Calcium ionised increased
20-29:
n/a
30-39:
- Headache (pain in head)
- Parosmia (distortion of the sense of smell, as in smelling odours that are not present)
40-49:
- Drug hypersensitivity
- Headache (pain in head)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Weight increased
50-59:
- Mouth ulceration (mouth ulcers)
- Oropharyngeal plaque (hard deposit on oropharynx)
- Periodontitis (inflammation of the tissue around the teeth)
- Stomatitis (inflammation of mucous membrane of mouth)
- Oropharyngeal pain
- Back pain
- Headache (pain in head)
- Neck pain
- Neuritis (inflammation of nerve)
- Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
60+:
- Fall
- Pneumonia
- Asthenia (weakness)
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Gingivitis (inflammation of gums)
- Hypertension (high blood pressure)
- Insomnia (sleeplessness)
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
What are the existing conditions these people have? *
- Pain: 21 people, 25.93%
- Osteoporosis (bones weak and more likely to break): 18 people, 22.22%
- High Blood Cholesterol: 16 people, 19.75%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 18.52%
- Osteopenia (a condition where bone mineral density is lower than normal): 13 people, 16.05%
- Dyspnea (difficult or laboured breathing): 13 people, 16.05%
- Arthropod Sting (arthropod bite): 13 people, 16.05%
- High Blood Pressure: 7 people, 8.64%
- Breast Cancer: 6 people, 7.41%
- Asthma: 5 people, 6.17%
* Approximation only. Some reports may have incomplete information.
Do you take Relafen and Centrum?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Relafen and Centrum:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Relafen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Centrum:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Relafen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Centrum and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on nabumetone and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Relafen and Centrum, respectively), and Relafen and Centrum (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Joint Pain and drugs of ingredients of ofatumumab - 7 seconds ago
- Drug interactions of Adalat and Lidocaine - 10 seconds ago
- Drug interactions of Potassium and Mirabegron - 12 seconds ago
- Drug interactions of Atropine Sulfate and Doxycycline Hyclate - 13 seconds ago
- Drug interactions of Micardis and Ceftriaxone - 25 seconds ago
- Mood Swings in Adderall Xr 20, how severe and when it was recovered? - 27 seconds ago
- Drug interactions of Norco and Methylprednisolone Sodium Succinate - 28 seconds ago
- Ginkgo and Vitamin E drug interactions for women aged 60+ - 45 seconds ago
- Levothroid and Revatio drug interactions for men aged 60+ - 49 seconds ago
- Blood Folate Decreased and drugs of ingredients of methylprednisolone sodium succinate - 52 seconds ago